RAFAEL HOLDINGS, INC. Equity Method Investments
RAFAEL HOLDINGS, INC. (RFL) had Equity Method Investments of $7.00 million as of 2021-07-31, per its 10-K filed 2021-10-18.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2021-10-18
- 2021-07-31: Equity Method Investments $7.00M.
- 2021-04-30: Equity Method Investments $7.00M.
- 2021-01-31: Equity Method Investments $7.00M.
| Period end | Equity Method Investments |
|---|---|
| 2021-07-31 | $7.00M 10-K · filed 2021-10-18 |
| 2021-04-30 | $7.00M 10-Q · filed 2021-06-14 |
| 2021-01-31 | $7.00M 10-Q · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |